Navigation Links
Bhopal Gas Victims Get Spurious Drugs, Say Activists

Terming it as a 'citizens raid', Bhopal gas tragedy survivors' organisations claimed //to have seized a large number of sub-standard and expired drugs from two medical stores of the Bhopal Gas Tragedy Relief and Rehabilitation Department.

"A joint team of four organisations, working for the victims of the world's worst man-made industrial disaster, recovered many medicines that had crossed their expiry date," Rachna Dhingra of Bhopal Group of Information and Action (BGIA) said.

Addressing a press conference, she said of the 83 samples collected, more than 30 had passed their expiry date. The outdated medicines were antibiotics such as norfloxacin, ampicillin and tetracyclin.

Members of three other survivors' organisations - Bhopal Gas Peedit Mahila Stationery Karmachari Sangh (BGPMSKS), Bhopal Gas Peedit Mahila Purush Sangharsh Morcha (BGPMPSM) and Bhopal ki Awaaz (BKA) - were also present on the occasion.

"More than half of the samples collected were of medicines manufactured in Indore which is notorious for manufacturing spurious drugs," they said.

The activists alleged that despite the Supreme Court directives to send random samples of medicines for test at reputed laboratories, the state government has not taken any step in this regard.



Source-IANS
'"/>




Page: 1

Related medicine news :

1. Doctors Resign from Hospital for Bhopal Gas Victims
2. Bhopal Residents Relish Chicken despite Bird Flu Scare
3. State Govt To Provide Safe Drinking Water To Bhopal Gas Victims
4. Bhopal Archbishop’s Concern Over Maternal Mortality Rat
5. Six More Bhopal Gas Tragedy Continues to Take Toll
6. 500 People Affected by Gas Leak Near Bhopal
7. Children of Bhopal Gas Victims Suffer from Deformity
8. Funds Increased for Treating Bhopal Gas Victims
9. Bhopal Gas Victims Demand Treatment of Children With Birth Defects
10. Snail venom Found To Ease Pain In Cancer Victims
11. Patients Suffering From Severe Mental Diseases Are At Risk Of Being Crime Victims
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2017)... ... 2017 , ... CareSet Labs released the Root NPI Graph today at the ... greatly improved version of the Doctor Referral teaming dataset commonly available from Medicare. , ... called the the “Doctor Referral Dataset” as released by Medicare and “DocGraph” as released ...
(Date:6/24/2017)... ... June 24, 2017 , ... ... at 217 Portion Road in Lake Ronkonkoma, Dental365 offers patients high-quality and affordable ... that visits to the dentist fit into their patients’ busy lifestyles. Dental365 also ...
(Date:6/23/2017)... CA (PRWEB) , ... June 23, 2017 , ... By ... earned its ninth consecutive four-star rating from premier online charity evaluator, Charity Navigator, validating ... the top 1% of all charities reviewed by Charity Navigator and earns ANRF a ...
(Date:6/23/2017)... ... June 23, 2017 , ... Military Connection friend ... entry to the JFK Virgin Atlantic lounge. , Bensko is no stranger to ... years ago, Bensko dedicated her life to supporting our wounded veterans. A world-class photographer, ...
(Date:6/23/2017)... , ... June 23, 2017 , ... ... Cancer Conference from Sept. 18 to 20. , The two-day conference is focused ... with the goal of improving patients’ lives and eliminating racial breast cancer-related disparities. ...
Breaking Medicine News(10 mins):
(Date:6/14/2017)... June 14, 2017 The Bio Supply Management ... City of Fremont and the Biomedical Manufacturing ... industry in California by providing ... networking, and fostering workforce development. The primary focus of ... of start-ups, as well as small and mid-sized biomedical ...
(Date:6/13/2017)... -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a ... Food and Drug Administration (FDA) has notified the Company that ... Zhejiang, China manufacturing facility has been ... clearance of the Warning Letter related to our ... of the progress we have made in our ongoing quality ...
(Date:6/11/2017)... , June 10, 2017  Eli Lilly and Company (NYSE: ... three Phase 3 studies of galcanezumab, an investigational treatment ... late-breaking data on several key secondary endpoints for galcanezumab ... from these studies (EVOLVE-1, EVOLVE-2 and REGAIN) will be ... scientific meeting in Boston . ...
Breaking Medicine Technology: